Tumor suppressor genes in normal and malignant hematopoiesis
- 13 May 2002
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 21 (21), 3475-3495
- https://doi.org/10.1038/sj.onc.1205322
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 329 references indexed in Scilit:
- Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in b-cell non-Hodgkin's lymphomaInternational Journal of Cancer, 2000
- Wilms' Tumor Gene Product WT1 Arrests Macrophage Differentiation of HL-60 Cells Through Its Zinc-Finger DomainBiochemical and Biophysical Research Communications, 1999
- Genetic Alterations in the Retinoblastoma Protein-Related p107 Gene in Human Hematologic MalignanciesBiochemical and Biophysical Research Communications, 1998
- Codeletion ofCDKN2 andMTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphomaGenes, Chromosomes and Cancer, 1998
- Book reviewInfection, 1997
- Delineation of a 6 cM commonly deleted region in childhood acute lymphoblastic leukemia on the 6q chromosomal armLeukemia, 1997
- P53 Tumor suppressor gene in chronic myelogenous leukemia: A sequential studyAnnals of Hematology, 1995
- p 53 gene rearrangements in chronic myelocytic leukemiaAnnals of Hematology, 1993
- Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesisNature, 1992
- Effects of an Rb mutation in the mouseNature, 1992